New research in The FASEB Journal suggests that white blood cells exposed to UVA light in agar, to induce DNA damage, can predict if one has or is at risk for cancer
A new research report published in the October 2014 issue of The FASEB Journal may make the early detection of cancer as easy as a simple blood test. This test, called the “lymphocyte genome sensitivity” (LGS) test, could not only detect some cancers earlier than ever before, but it may eliminate the need for some types of biopsies, as well as identify those more likely to develop cancer in the future.
“The test could allow earlier cancer detection, so helping to save peoples’ lives,” said Diana Anderson, a researcher involved in the work from the School of Life Sciences at the University of Bradford in West Yorkshire, United Kingdom.
To develop this test, Anderson and colleagues took blood samples from a group of people that included healthy individuals, cancer patients and people believed to be at a higher risk than normal to develop cancer. White blood cells (lymphocytes) in these samples were examined in a Comet test, by embedding the cells in a jelly-like substance, called agar, on a microscope slide. In this test, damage to the genetic material (DNA) of the cells was caused by treatment with ultraviolet (UVA) light. This damage was observed in the form of DNA pieces being pulled within the agar in an electric field toward the positive end of the field. This caused a comet-like tail, and the longer the tail the more DNA damage. Different thicknesses of the agar were applied to the slides. In healthy people, as different thicknesses were added, DNA-damaged tail responses returned to normal levels. In cancer patients, DNA-damaged tail responses remained high and in those people who might develop pre-cancerous diseases, tail responses were in between. This means that people with cancer have DNA which is more easily damaged by UVA than do other people, so the test shows the sensitivity to damage of all the genome in a cell. The LGS test has been used to examine blood samples from cancer patients with melanoma, colon cancer and lung cancer, and all gave the same outcomes.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Blood Tests can Predict Who's at Higher Risk for Severe Covid-19on February 27, 2021 at 12:20 am
Five biomarkers or biological signals, which are linked to activating white blood cells and obesity can predict severe outcomes in COVID-19 patients. These critically ill patients require care in the ...
- My prostate cancer journey: Testosterone reduction, mini-radiation treatments, embedded radioactive seeds and lots of difficult side effectson February 26, 2021 at 3:50 pm
The year-long treatment’s effects made many things harder. And those seeds mean I might set off radiation detectors at borders and I can’t let my grandkids sit on my lap.
- Prostate cancer symptoms: ‘Burning’ wee could be an early sign of the deadly diseaseon February 26, 2021 at 4:03 am
PROSTATE cancer is the most common cancer in men in the UK. It tends to develop slowly, meaning there may be no signs for many years, so spotting symptoms when they appear is very important. One sign ...
- Living through and beyond Canceron February 26, 2021 at 1:01 am
Cancer can start almost anywhere in the body, spreading around and causing tumors. Blood cancer is one of the most common types of cancer but 48-year-old Sanjeev Goel had the rarest of leukemia, Hairy ...
- The Game Changer: New Test Helps Doctors Find Hidden Prostate Canceron February 25, 2021 at 11:38 pm
New technology is making it easier for doctors to detect prostate cancer in men and could prove to be an effective treatment for the disease.
- Lung cancer symptoms: The simple finger test to find out if you’re at risk of the diseaseon February 25, 2021 at 12:02 am
LUNG cancer isn't reserved for older smokers, anyone can develop the deadly condition - and it's the most common cause of cancer death for both genders. Thankfully, an early diagnosis can make a big ...
- Responses to Therapy for Ovarian and Other Women’s Cancers May Have to be Assessed Beyond Imaging and Blood Test Modalitieson February 24, 2021 at 8:04 am
Two evaluations for treatment responses in women with ovarian, fallopian tub or primary peritoneal carcinoma may need to take into consideration other factors such as other existing conditions.
- Chosen wisely: Grail, Quest team up on cancer blood teston February 23, 2021 at 6:45 am
In a gift to your headline writer, Grail has tapped testing giant Quest Diagnostics to help roll out its upcoming multi-cancer blood test.
- Do Home Cancer Tests Work as Well as a Colonoscopy?on February 22, 2021 at 2:15 pm
there are at-home tests you can do to detect colorectal cancer by collecting samples of your own stool. You send the samples to a lab for analysis of the presence of occult or hidden blood in the ...
- Highly sensitive blood test for cancer wins 2021 Top 10 Clinical Research Achievement Awardon February 21, 2021 at 9:20 am
Cancer biologists at Weill Cornell Medicine have been awarded a 2021 Top 10 Clinical Research Achievement Award from the Clinical Research Forum for their study last year describing a highly sensitive ...
via Bing News